Indicadores nutricionales como biomarcadores predictivos y de pronóstico para los resultados de la quimioradioterapia

Zhenyong Shao1, Yihe Zou2, Changlin Zou3

  • 1Department of Radiotherapy, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, 310058, Zhejiang Province, China.

Resumen

Los niveles de glóbulos rojos y hemoglobina predicen la eficacia de la quimioradioterapia neoadyuvante (nCRT) en el cáncer rectal localmente avanzado (LARC). El mantenimiento de un buen estado nutricional mejora la respuesta al tratamiento y los resultados de supervivencia de los pacientes con LARC.

Videos de Conceptos Relacionados

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
407
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K